Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
69 studies found for:    Open Studies | "Bone Diseases, Infectious"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Bone Diseases, Infectious"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Delaying Ossification and Improving Inflammation of Celebrex Plus/or Enbrel Treatment on Active Ankylosing Spondylitis
Conditions: Inflammation;   Ankylosing Spondylitis
Interventions: Drug: celebrex;   Drug: Enbrel;   Drug: Enbrel plus Celebrex
2 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS)
Condition: Ankylosing Spondylitis
Intervention: Biological: Human umbilical cord-derived MSCs
3 Recruiting Extension in AS: Sustainability of Benefits, Safety and Tolerability
Condition: Spondylitis, Ankylosing
Intervention: Biological: Secukinumab
4 Recruiting Registry of Korean Patients With Rheumatic Disease Using Biologics
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
5 Not yet recruiting Physical Training Program in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Other: Personalized physical training program
6 Recruiting Employment and Arthritis: Making it Work
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Lupus Erythematosus, Systemic;   Psoriatic Arthritis;   Other Connective Tissue Diseases;   Spondylarthropathy
Intervention: Behavioral: Employment and Arthritis: Making it Work
7 Recruiting A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
8 Unknown  Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: rituximab
9 Not yet recruiting 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Interventions: Biological: Secukinumab;   Biological: Placebo
10 Recruiting 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients
Condition: Spondylitis, Ankylosing
Interventions: Drug: Secukinumab;   Drug: Placebo secukinumab
11 Recruiting Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for the Treatment of Diabetic Foot Osteomyelitis
Condition: Osteomyelitis
Interventions: Drug: piperacillin/tazobactam, cefepime, metronidazole, aztreonam,vancomycin, daptomycin, linezolid ,meropenem;   Drug: sulfamethoxazole/trimethoprim , clindamycin ,linezolid, moxifloxacin ,ciprofloxacin ,metronidazole
12 Recruiting The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
Conditions: Chronic Low Back Pain;   Axial Spondyloarthritis
Intervention: Other: Applying a referral model
13 Recruiting Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy
Condition: Ankylosing Spondylitis
Intervention: Other: no intervention
14 Recruiting The Effect of Acupuncture Protocol Involving in Weizhong (BL4) and Huantiao (GB30) Points in Treating Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Other: Weizhong and Huantiao;   Other: A-shi point
15 Recruiting BI 655066 Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)
Condition: Spondylitis, Ankylosing
Interventions: Drug: Placebo;   Drug: BI 655066
16 Unknown  Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)
Condition: Moderate to Severe Active Axial Spondyloarthritis
Interventions: Drug: Etanercept 25mg;   Drug: Sulfasalazine
17 Recruiting Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Thalidomide 150mg;   Drug: Thalidomide 100mg;   Drug: Placebo
18 Unknown  Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity
Condition: Spondyloarthritis
Intervention: Drug: Adalimumab, Etanercept, or infliximab
19 Not yet recruiting PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
Conditions: Cardiac Disease;   Dementia;   Inflammatory Disease;   Fever of Unknown Origin;   Vasculitis;   Osteomyelitis;   FDG Avid Cancers
Interventions: Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
20 Unknown  Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis
Condition: Spondyloarthritis
Interventions: Drug: Adalimumab;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years